CENTURY(SZ:300078)2018-04-25 16:00Financial Performance - Total revenue for Q1 2018 was CNY 236,055,985.39, an increase of 11.01% compared to CNY 212,645,594.51 in the same period last year[7]. - Net profit attributable to shareholders decreased by 33.79% to CNY 22,544,913.35 from CNY 34,052,438.07 year-on-year[7]. - Basic and diluted earnings per share both decreased by 25.00% to CNY 0.03 from CNY 0.04[7]. - Operating profit decreased by 39.02% to ¥23,730,123.26 from ¥38,915,389.75, impacted by increased expenses and decreased other income[21]. - The net profit attributable to shareholders was 22.54 million yuan, a decrease of 33.79% compared to the same period last year[22]. - The net profit for Q1 2018 was a loss of ¥4,184,189.43, compared to a profit of ¥59,951,673.82 in the same period last year[50]. - The company reported a total comprehensive income of -¥4,184,189.43 for Q1 2018, down from ¥59,951,673.82 in the previous year[51]. Cash Flow and Liquidity - Net cash flow from operating activities was negative at CNY -77,598,479.45, worsening by 10.50% compared to CNY -70,225,427.84 in the previous year[7]. - The company's cash and cash equivalents decreased by 41.62% to ¥250,809,879.48 from ¥429,625,738.95, primarily due to seasonal operational factors, repayment of bank loans, and external investments[21]. - Cash and cash equivalents at the end of Q1 2018 were ¥250,809,879.48, down from ¥382,702,053.96 at the end of the previous period[55]. - Cash flow from investing activities shows a net outflow of -19,992,548.04 CNY, compared to a net inflow of 18,872,823.04 CNY in the previous period[58]. - Cash inflow from financing activities is 145,121,500.00 CNY, with a net cash flow of 86,489,457.31 CNY, a significant improvement from -243,390,268.32 CNY in the previous period[59]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,882,304,059.69, a decrease of 0.67% from CNY 2,901,704,986.98 at the end of the previous year[7]. - The total liabilities decreased to CNY 750,162,316.24 from CNY 789,622,076.66, indicating a reduction of 5.0%[41]. - The company's long-term borrowings increased by 48.13% to ¥192,567,500.00, due to new domestic foreign debt[21]. - Short-term borrowings decreased from CNY 322,800,000.00 to CNY 277,352,400.00, a decline of approximately 14.1%[39]. Market and Competition - The company faced intensified market competition in the global retail security market and the domestic RFID market, impacting its smart healthcare business[9]. - The company plans to enhance its technology and service capabilities to maintain its market influence and brand recognition amid competitive pressures[9]. - The RFID label business experienced a decline in overall sales in North America due to delayed payments from certain clients, impacting the commercial intelligence segment[23]. - The company faces intensified market competition in the retail security market and the smart medical sector, prompting a focus on technological and service differentiation[25]. Intellectual Property and Development - The company obtained 17 software copyrights, 15 utility model patents, and 10 design patents during the reporting period, enhancing its intellectual property portfolio[24]. - The company plans to strengthen its technology research and development and market promotion efforts in response to favorable government policies in the medical information industry[22]. Shareholder Information - The total number of shareholders at the end of the reporting period was 55,068[12]. - The largest shareholder, Lu Nan, held 16.33% of the shares, amounting to 131,905,000 shares[12]. - The company has implemented a performance commitment related to the acquisition of shares from major shareholders[30]. - The company is actively monitoring the fulfillment of performance commitments and related shareholder obligations[30].